A novel genetic circuitry governing hypoxic metabolic flexibility, commensalism and virulence in the fungal pathogen Candida albicans.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
12 2019
Historique:
received: 03 05 2019
accepted: 18 10 2019
revised: 18 12 2019
pubmed: 7 12 2019
medline: 29 2 2020
entrez: 7 12 2019
Statut: epublish

Résumé

Inside the human host, the pathogenic yeast Candida albicans colonizes predominantly oxygen-poor niches such as the gastrointestinal and vaginal tracts, but also oxygen-rich environments such as cutaneous epithelial cells and oral mucosa. This suppleness requires an effective mechanism to reversibly reprogram the primary metabolism in response to oxygen variation. Here, we have uncovered that Snf5, a subunit of SWI/SNF chromatin remodeling complex, is a major transcriptional regulator that links oxygen status to the metabolic capacity of C. albicans. Snf5 and other subunits of SWI/SNF complex were required to activate genes of carbon utilization and other carbohydrates related process specifically under hypoxia. snf5 mutant exhibited an altered metabolome reflecting that SWI/SNF plays an essential role in maintaining metabolic homeostasis and carbon flux in C. albicans under hypoxia. Snf5 was necessary to activate the transcriptional program linked to both commensal and invasive growth. Accordingly, snf5 was unable to maintain its growth in the stomach, the cecum and the colon of mice. snf5 was also avirulent as it was unable to invade Galleria larvae or to cause damage to human enterocytes and murine macrophages. Among candidates of signaling pathways in which Snf5 might operate, phenotypic analysis revealed that mutants of Ras1-cAMP-PKA pathway, as well as mutants of Yak1 and Yck2 kinases exhibited a similar carbon flexibility phenotype as did snf5 under hypoxia. Genetic interaction analysis indicated that the adenylate cyclase Cyr1, a key component of the Ras1-cAMP pathway interacted genetically with Snf5. Our study yielded new insight into the oxygen-sensitive regulatory circuit that control metabolic flexibility, stress, commensalism and virulence in C. albicans.

Identifiants

pubmed: 31809527
doi: 10.1371/journal.ppat.1007823
pii: PPATHOGENS-D-19-00838
pmc: PMC6919631
doi:

Substances chimiques

Fungal Proteins 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007823

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI118898
Pays : United States
Organisme : CIHR
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eukaryot Cell. 2012 Jul;11(7):916-31
pubmed: 22581526
Science. 1994 Dec 9;266(5191):1723-6
pubmed: 7992058
Eukaryot Cell. 2014 May;13(5):675-90
pubmed: 24681685
PLoS Pathog. 2015 Aug 28;11(8):e1005133
pubmed: 26317337
Mol Cell Biol. 1997 Aug;17(8):4811-9
pubmed: 9234737
Oncogenesis. 2016 Jan 25;5:e190
pubmed: 26807645
PLoS Pathog. 2017 Feb 9;13(2):e1006144
pubmed: 28182769
Biochem J. 1993 May 1;291 ( Pt 3):765-71
pubmed: 8489504
PLoS Pathog. 2012 Feb;8(2):e1002525
pubmed: 22359502
Genes Dev. 2018 May 1;32(9-10):695-710
pubmed: 29785963
PLoS Biol. 2013;11(3):e1001510
pubmed: 23526879
Eukaryot Cell. 2004 Oct;3(5):1076-87
pubmed: 15470236
BMC Genomics. 2011 Dec 22;12:628
pubmed: 22192698
Cancer Cell. 2012 Mar 20;21(3):297-308
pubmed: 22439925
PLoS Biol. 2010 Jul 06;8(7):e1000414
pubmed: 20625544
Chem Biol. 2014 Nov 20;21(11):1423-32
pubmed: 25442374
PLoS Pathog. 2017 Jun 1;13(6):e1006414
pubmed: 28570675
Eukaryot Cell. 2013 Jan;12(1):37-49
pubmed: 23125349
Microb Cell. 2018 Sep 29;5(11):482-494
pubmed: 30483520
mBio. 2018 Nov 6;9(6):
pubmed: 30401781
G3 (Bethesda). 2018 Mar 28;8(4):1299-1314
pubmed: 29472308
Mol Microbiol. 2017 Jun;104(6):989-1007
pubmed: 28337802
Curr Biol. 2014 Oct 20;24(20):2411-6
pubmed: 25308076
mSphere. 2017 Nov 15;2(6):null
pubmed: 29152582
PLoS Pathog. 2009 Oct;5(10):e1000612
pubmed: 19816560
PLoS Genet. 2009 Dec;5(12):e1000783
pubmed: 20041210
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1171-7
pubmed: 20153717
PLoS Pathog. 2007 Feb;3(2):e22
pubmed: 17319742
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Mol Syst Biol. 2009;5:319
pubmed: 19888214
Mycopathologia. 2014 Dec;178(5-6):331-9
pubmed: 24996522
Nucleic Acids Res. 2014 Apr;42(7):4270-82
pubmed: 24465003
Yeast. 2003 Dec;20(16):1339-47
pubmed: 14663826
Front Microbiol. 2019 Jan 30;10:99
pubmed: 30761119
mBio. 2013 Feb 05;4(1):e00034-13
pubmed: 23386434
Curr Biol. 2005 Nov 22;15(22):2021-6
pubmed: 16303561
Infect Immun. 2008 Sep;76(9):4345-58
pubmed: 18625733
F1000Res. 2016 Oct 26;5:2582
pubmed: 27853524
Eukaryot Cell. 2009 Aug;8(8):1174-83
pubmed: 19542309
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell Rep. 2017 Feb 28;18(9):2124-2134
pubmed: 28249159
Mol Microbiol. 2019 Jan;111(1):6-16
pubmed: 30299574
PLoS Genet. 2015 Aug 14;11(8):e1005447
pubmed: 26274602
Am J Physiol Cell Physiol. 2011 Mar;300(3):C385-93
pubmed: 21123733
Cold Spring Harb Perspect Med. 2014 Sep 04;4(12):a019695
pubmed: 25190251
Mol Microbiol. 2011 May;80(4):995-1013
pubmed: 21414038
J Biol Chem. 2015 Oct 9;290(41):24715-26
pubmed: 26309257
Cell Rep. 2017 Feb 28;18(9):2135-2147
pubmed: 28249160
Curr Opin Microbiol. 2010 Jun;13(3):382-8
pubmed: 20439164
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807921
Eukaryot Cell. 2010 Nov;9(11):1734-46
pubmed: 20870877
Mol Cell Biol. 2004 Feb;24(3):1232-44
pubmed: 14729968
Mol Cell Biol. 2002 Mar;22(6):1615-25
pubmed: 11865042
BMC Microbiol. 2009 Feb 02;9:25
pubmed: 19187560
mBio. 2016 Sep 20;7(5):
pubmed: 27651366
mBio. 2018 Nov 6;9(6):
pubmed: 30401773
Elife. 2016 Sep 10;5:
pubmed: 27614020
Microb Cell. 2017 Dec 18;5(2):63-73
pubmed: 29417055
PLoS Biol. 2015 Feb 18;13(2):e1002076
pubmed: 25693184
Eukaryot Cell. 2010 Feb;9(2):251-65
pubmed: 20023067
J Mol Biol. 2006 Aug 18;361(3):399-411
pubmed: 16854431
J Bacteriol. 1992 Nov;174(21):6992-6
pubmed: 1400249
Cell Microbiol. 2009 Feb;11(2):183-90
pubmed: 19016786
mBio. 2012 Dec 11;3(6):null
pubmed: 23232717
Eukaryot Cell. 2002 Oct;1(5):657-62
pubmed: 12455685
Nat Rev Microbiol. 2011 Dec 12;10(2):112-22
pubmed: 22158429
PLoS Pathog. 2007 Dec;3(12):e184
pubmed: 18069889
J Biol Chem. 2015 Jul 3;290(27):16786-96
pubmed: 25947383
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Genetics. 2012 Feb;190(2):351-87
pubmed: 22345607
Genes Dev. 2007 Jan 15;21(2):148-59
pubmed: 17167106
BMC Genomics. 2015 Sep 05;16:683
pubmed: 26341223
Front Cell Infect Microbiol. 2017 Aug 17;7:368
pubmed: 28861398
Front Microbiol. 2019 Feb 25;10:327
pubmed: 30858840
Trends Microbiol. 2014 Nov;22(11):614-22
pubmed: 25088819
Annu Rev Microbiol. 2013;67:291-312
pubmed: 23808338
Nat Genet. 2010 Jul;42(7):590-8
pubmed: 20543849

Auteurs

Anaïs Burgain (A)

CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada.
Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.

Émilie Pic (É)

CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada.

Laura Markey (L)

Program in Molecular Microbiology, Tufts University, Boston, Massachusetts, United States of America.
Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America.

Faiza Tebbji (F)

CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada.

Carol A Kumamoto (CA)

Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America.

Adnane Sellam (A)

CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada.
Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.
Big Data Research Centre (BDRC-UL), Université Laval, Faculty of Sciences and Engineering, Quebec City, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH